Christopher Daley

Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375

J. Uslaner, F. Thomson, A. Harvey, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.

Paul Zuck, K. K. Nanda, D. Henze, 2014, Journal of medicinal chemistry.

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice.

Edward C Sherer, John Majercak, Deping Wang, 2017, Bioorganic & medicinal chemistry letters.

Nav1.7 target modulation and efficacy can be measured in nonhuman primate assays

D. Henze, Yuxing Li, R. Kraus, 2021, Science Translational Medicine.

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model.

Michael A Rossi, D. Henze, J. Majercak, 2017, Bioorganic & medicinal chemistry letters.

Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.

K. K. Nanda, D. Henze, M. Rudd, 2014, Journal of medicinal chemistry.